| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |